115 related articles for article (PubMed ID: 27558368)
1. Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation.
Fernández-Torrón R; García-Puga M; Emparanza JI; Maneiro M; Cobo AM; Poza JJ; Espinal JB; Zulaica M; Ruiz I; Martorell L; Otaegui D; Matheu A; López de Munain A
Neurology; 2016 Sep; 87(12):1250-7. PubMed ID: 27558368
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
3. Cancer risk among patients with myotonic muscular dystrophy.
Gadalla SM; Lund M; Pfeiffer RM; Gørtz S; Mueller CM; Moxley RT; Kristinsson SY; Björkholm M; Shebl FM; Hilbert JE; Landgren O; Wohlfahrt J; Melbye M; Greene MH
JAMA; 2011 Dec; 306(22):2480-6. PubMed ID: 22166607
[TBL] [Abstract][Full Text] [Related]
4. Cardiac involvement in myotonic dystrophy: a nationwide cohort study.
Lund M; Diaz LJ; Ranthe MF; Petri H; Duno M; Juncker I; Eiberg H; Vissing J; Bundgaard H; Wohlfahrt J; Melbye M
Eur Heart J; 2014 Aug; 35(32):2158-64. PubMed ID: 24742887
[TBL] [Abstract][Full Text] [Related]
5. Increased cancer risks in myotonic dystrophy.
Win AK; Perattur PG; Pulido JS; Pulido CM; Lindor NM
Mayo Clin Proc; 2012 Feb; 87(2):130-5. PubMed ID: 22237010
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of myotonic dystrophy type 1 (Steinert disease) in Belgrade (Serbia).
Mladenovic J; Pekmezovic T; Todorovic S; Rakocevic-Stojanovic V; Savic D; Romac S; Apostolski S
Clin Neurol Neurosurg; 2006 Dec; 108(8):757-60. PubMed ID: 16713671
[TBL] [Abstract][Full Text] [Related]
7. microRNA-mRNA expression profiles in the skeletal muscle of myotonic dystrophy type 1.
Li M; Li Y; Wang Z; Cui F; Yang F; Wang H; Shi Q; Huang X
Neurol Res; 2024 Jul; 46(7):613-625. PubMed ID: 38810890
[TBL] [Abstract][Full Text] [Related]
8. Diabetes, metformin and cancer risk in myotonic dystrophy type I.
Alsaggaf R; Pfeiffer RM; Wang Y; St George DMM; Zhan M; Wagner KR; Amr S; Greene MH; Gadalla SM
Int J Cancer; 2020 Aug; 147(3):785-792. PubMed ID: 31749144
[TBL] [Abstract][Full Text] [Related]
9. Survival patterns and cancer determinants in families with myotonic dystrophy type 1.
Best AF; Hilbert JE; Wood L; Martens WB; Nikolenko N; Marini-Bettolo C; Lochmüller H; Rosenberg PS; Moxley RT; Greene MH; Gadalla SM
Eur J Neurol; 2019 Jan; 26(1):58-65. PubMed ID: 30051542
[TBL] [Abstract][Full Text] [Related]
10. [Increasing risk of tumors in myotonic dystrophy type 1].
Mohamed S; Pruna L; Kaminsky P
Presse Med; 2013 Sep; 42(9 Pt 1):e281-4. PubMed ID: 23477718
[TBL] [Abstract][Full Text] [Related]
11. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
[TBL] [Abstract][Full Text] [Related]
12. Benign tumors in myotonic dystrophy type I target disease-related cancer sites.
Alsaggaf R; St George DMM; Zhan M; Pfeiffer RM; Wang Y; Anderson LA; Liu Z; Koshiol J; Bauer AJ; Wagner KR; Greene MH; Amr S; Gadalla SM
Ann Clin Transl Neurol; 2019 Aug; 6(8):1510-1518. PubMed ID: 31402615
[TBL] [Abstract][Full Text] [Related]
13. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors.
Bianchi ML; Leoncini E; Masciullo M; Modoni A; Gadalla SM; Massa R; Rastelli E; Terracciano C; Antonini G; Bucci E; Petrucci A; Costanzi S; Santoro M; Boccia S; Silvestri G
J Neurol; 2016 Mar; 263(3):492-8. PubMed ID: 26739382
[TBL] [Abstract][Full Text] [Related]
15. Cancer incidence in the US radiologic technologists health study, 1983-1998.
Sigurdson AJ; Doody MM; Rao RS; Freedman DM; Alexander BH; Hauptmann M; Mohan AK; Yoshinaga S; Hill DA; Tarone R; Mabuchi K; Ron E; Linet MS
Cancer; 2003 Jun; 97(12):3080-9. PubMed ID: 12784345
[TBL] [Abstract][Full Text] [Related]
16. Risk of malignant neoplasms after liver transplantation: a population-based study.
Aberg F; Pukkala E; Höckerstedt K; Sankila R; Isoniemi H
Liver Transpl; 2008 Oct; 14(10):1428-36. PubMed ID: 18825704
[TBL] [Abstract][Full Text] [Related]
17. Micro-RNA expression in muscle and fiber morphometry in myotonic dystrophy type 1.
Fritegotto C; Ferrati C; Pegoraro V; Angelini C
Neurol Sci; 2017 Apr; 38(4):619-625. PubMed ID: 28078570
[TBL] [Abstract][Full Text] [Related]
18. [Standardized incidence ratios for cancers in Taiwan aborigines, 1981-1987].
Wang TN; Chang SJ; Ko YC
Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 Jul; 10(7):392-404. PubMed ID: 8089874
[TBL] [Abstract][Full Text] [Related]
19. The Mef2 transcription network is disrupted in myotonic dystrophy heart tissue, dramatically altering miRNA and mRNA expression.
Kalsotra A; Singh RK; Gurha P; Ward AJ; Creighton CJ; Cooper TA
Cell Rep; 2014 Jan; 6(2):336-45. PubMed ID: 24412363
[TBL] [Abstract][Full Text] [Related]
20. [Incidence of cancer in individuals with Down syndrome].
Hasle H; Clemmensen IH; Mikkelsen M
Tidsskr Nor Laegeforen; 2000 Oct; 120(24):2878-81. PubMed ID: 11143409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
